GP-Act III Acquisition (GPAT) Liabilities and Shareholders Equity (2023 - 2025)

GP-Act III Acquisition has disclosed Liabilities and Shareholders Equity across 3 years of filings, most recently posting $309.4 million for Q4 2025.

• Quarterly Liabilities and Shareholders Equity rose 4.0% year-over-year to $309.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 billion (up 38.09% YoY) and the FY2025 annual result came in at $309.4 million, up 4.0% from the prior year.
• Liabilities and Shareholders Equity climbed to $309.4 million in Q4 2025, from $306.5 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $309.4 million in Q4 2025 and troughed at $530238.0 in Q4 2023.
• A 3-year average of $233.7 million and a median of $297.5 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity soared 56001.91% — and 2025, when it increased 4.0%.
• Tracing GPAT's Liabilities and Shareholders Equity over 3 years: stood at $530238.0 in 2023, then surged by 56001.91% to $297.5 million in 2024, then rose by 4.0% to $309.4 million in 2025.
• Business Quant data shows GPAT's Liabilities and Shareholders Equity at $309.4 million in Q4 2025, $306.5 million in Q3 2025, and $303.4 million in Q2 2025.